Semafore Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Semafore Pharmaceuticals Inc. (formerly ComChem Technologies) didn't start with a breakthrough scientific discovery. But the firm's founders encountered a unique opportunity along the way-through the work of Donald Durden, MD, PhD, at the Indiana University School of Medicine-and took advantage of it. Now Semafore is discovering and developing novel small molecules to treat cancer by targeting what the founders believe is the primary, non-redundant cell-signaling pathway for controlling cell survival and cell death.